Sciwind Biosciences
PrivateLast Round
IPO
Mar 23, 2026
Est. Valuation
$676M
Total Funding Raised
$336.48M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Sciwind Biosciences is a biopharmaceutical company that develops innovative therapies for the treatment of metabolic diseases, including obesity and type 2 diabetes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sciwind Biosciences Comparables
Compare Sciwind Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| QL Biopharm | 87% | |
| Verdiva Bio | 84% | |
| Kailera Therapeutics | 83% | |
Sciwind Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Mar 23, 2026 | ||||
| Growth Equity | Jan 10, 2025 | ||||
| Series D | Dec 1, 2024 | ||||
| Series C Extension | Mar 1, 2023 | ||||
| Series C Extension | Dec 1, 2021 | ||||
Series C | Oct 12, 2021 |
Sciwind Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Loyal Valley Capital | Series C |
| IDG Capital | Series C |
| Oriza Holdings | Series B |
| Kaitai Capital | Series B |
| China International Capital Corporation | IPO |
| LYFE Capital | Series C, Series B |
| Legend Capital | Series C, Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors increased 169% MoM.
- Apr 17, 2026
Grew 43% QoQ from 7 to 10 employees.
Sciwind Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sciwind Biosciences's valuation, stock price, and market status.